Mark G. Currie, Chief Scientific Officer at IRONWOOD PHARMACEUTICALS INC (IRWD), sold 150,000 shares at $10.86 ($1.6M) on 2016-03-09, disclosed to the SEC on 2016-03-11.
Open-market sale of $1.6M IRWD by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| IRWD | SELL | 2021-06-16 | $546K | — | Filing → |
| CYCN | SELL | 2020-12-30 | $121K | — | Filing → |
| IRWD | SELL | 2020-01-24 | $755K | — | Filing → |